EGF-receptor-mediated mammary epithelial cell migration is driven by sustained ERK signaling from autocrine stimulation

EGF family ligands are synthesized as membrane-anchored precursors whose proteolytic release yields mature diffusible factors that can activate cell surface receptors in autocrine or paracrine mode. Expression of these ligands is altered in pathological states and in physiological processes, such as development and tissue regeneration. Despite the widely documented biological importance of autocrine EGF signaling, quantitative relationships between protease-mediated ligand release and consequent cell behavior have not been rigorously investigated. We thus explored the relationship between autocrine EGF release rates and cell behavioral responses along with activation of ERK, a key downstream signal, by expressing chimeric ligand precursors and modulating their proteolytic shedding using a metalloprotease inhibitor in human mammary epithelial cells. We found that ERK activation increased monotonically with increasing ligand release rate despite concomitant downregulation of EGF receptor levels. Cell migration speed was directly related to ligand release rate and proportional to steady-state phospho-ERK levels. Moreover, migration speed was significantly greater for autocrine stimulation compared with exogenous stimulation, even at comparable phospho-ERK levels. By contrast, cell proliferation rates were approximately equivalent at all ligand release rates and were similar regardless of whether the ligand was presented endogenously or exogenously. Thus, in our mammary epithelial cell system, migration and proliferation are differentially sensitive to the mode of EGF ligand presentation.

[1]  J. Mendelsohn,et al.  Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity. , 1984, The Journal of biological chemistry.

[2]  D. Lauffenburger,et al.  Autocrine epidermal growth factor signaling stimulates directionally persistent mammary epithelial cell migration , 2001, The Journal of cell biology.

[3]  J. Massagué,et al.  Role of the Juxtamembrane Domains of the Transforming Growth Factor-α Precursor and the β-Amyloid Precursor Protein in Regulated Ectodomain Shedding* , 1997, The Journal of Biological Chemistry.

[4]  D. Lauffenburger,et al.  The membrane-anchoring domain of epidermal growth factor receptor ligands dictates their ability to operate in juxtacrine mode. , 2005, Molecular biology of the cell.

[5]  M. Mifune,et al.  Metalloprotease-dependent ErbB ligand shedding in mediating EGFR transactivation and vascular remodelling. , 2003, Biochemical Society transactions.

[6]  D A Lauffenburger,et al.  Interrupting autocrine ligand-receptor binding: comparison between receptor blockers and ligand decoys. , 1992, Biophysical journal.

[7]  P. Yaswen,et al.  Blockage of EGF receptor signal transduction causes reversible arrest of normal and immortal human mammary epithelial cells with synchronous reentry into the cell cycle. , 1993, Experimental cell research.

[8]  H. Steven Wiley,et al.  Cell Surface Receptors for Signal Transduction and Ligand Transport: A Design Principles Study , 2007, PLoS Comput. Biol..

[9]  D. Lauffenburger,et al.  Computational modeling of the EGF-receptor system: a paradigm for systems biology. , 2003, Trends in cell biology.

[10]  D A Lauffenburger,et al.  Real-time quantitative measurement of autocrine ligand binding indicates that autocrine loops are spatially localized. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  D. Lauffenburger,et al.  Metalloprotease-mediated ligand release regulates autocrine signaling through the epidermal growth factor receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Simon C Watkins,et al.  Spatiotemporal expression of angiogenesis growth factor receptors during the revascularization of regenerating rat liver , 2001, Hepatology.

[13]  V. Band,et al.  Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R. Harris,et al.  Autocrine, paracrine and juxtacrine signaling by EGFR ligands. , 2005, Cellular signalling.

[15]  Alan Wells,et al.  Membrane Proximal ERK Signaling Is Required for M-calpain Activation Downstream of Epidermal Growth Factor Receptor Signaling* , 2001, The Journal of Biological Chemistry.

[16]  A. Wells,et al.  Tumor invasion: role of growth factor-induced cell motility. , 2000, Advances in cancer research.

[17]  B. Kholodenko,et al.  Quantification of Short Term Signaling by the Epidermal Growth Factor Receptor* , 1999, The Journal of Biological Chemistry.

[18]  D A Lauffenburger,et al.  Spatial range of autocrine signaling: modeling and computational analysis. , 2001, Biophysical journal.

[19]  Eytan Domany,et al.  A module of negative feedback regulators defines growth factor signaling , 2007, Nature Genetics.

[20]  R. Klemke,et al.  ERK and RhoA Differentially Regulate Pseudopodia Growth and Retraction during Chemotaxis* , 2003, The Journal of Biological Chemistry.

[21]  D. Lauffenburger,et al.  Self-organization of polarized cell signaling via autocrine circuits: computational model analysis. , 2004, Biophysical journal.

[22]  L. Hertz,et al.  Depolarization-induced, glutamate receptor–mediated, and transactivation-dependent extracellular-signal regulated kinase phosphorylation in cultured cerebellar granule neurons , 2007, Neuroscience.

[23]  Lili X. Peng,et al.  A High-throughput Quantitative Multiplex Kinase Assay for Monitoring Information Flow in Signaling Networks , 2003, Molecular & Cellular Proteomics.

[24]  J. Massagué,et al.  Role of the juxtamembrane domains of the transforming growth factor-alpha precursor and the beta-amyloid precursor protein in regulated ectodomain shedding. , 1997, The Journal of biological chemistry.

[25]  J. Wilsbacher,et al.  An active form of Vav1 induces migration of mammary epithelial cells by stimulating secretion of an epidermal growth factor receptor ligand , 2006, Cell Communication and Signaling.

[26]  D. Lauffenburger,et al.  Autocrine EGF receptor activation mediates endothelial cell migration and vascular morphogenesis induced by VEGF under interstitial flow. , 2005, Experimental cell research.

[27]  M. Conti,et al.  Role of the Epidermal Growth Factor Network in Ovarian Follicles the Physiology of Follicle Maturation and Ovulation , 2022 .

[28]  Richard C Zangar,et al.  Induced Autocrine Signaling through the Epidermal Growth Factor Receptor Contributes to the Response of Mammary Epithelial Cells to Tumor Necrosis Factor α* , 2004, Journal of Biological Chemistry.

[29]  A. Ullrich,et al.  Mig-6 Is a Negative Regulator of the Epidermal Growth Factor Receptor Signal , 2001, Biological chemistry.

[30]  M. Kitamura,et al.  Construction of adenovirus vectors through Cre-lox recombination , 1997, Journal of virology.

[31]  D. Lauffenburger,et al.  A high-throughput migration assay reveals HER2-mediated cell migration arising from increased directional persistence. , 2006, Biophysical journal.

[32]  J. Segall,et al.  The great escape: when cancer cells hijack the genes for chemotaxis and motility. , 2005, Annual review of cell and developmental biology.

[33]  D A Lauffenburger,et al.  Quantitative analysis of the EGF receptor autocrine system reveals cryptic regulation of cell response by ligand capture. , 2001, Journal of cell science.

[34]  H. Wiley,et al.  Human mammary epithelial cells rapidly exchange empty EGFR between surface and intracellular pools , 1999, Journal of cellular physiology.

[35]  I. Bahar,et al.  [Epidermal growth factor receptor]. , 1994, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[36]  M. Washington,et al.  Ménétrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomach. , 2007, The Journal of clinical investigation.

[37]  S. Tremblay,et al.  HCaRG increases renal cell migration by a TGF-α autocrine loop mechanism , 2005 .

[38]  Douglas Lauffenburger,et al.  Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations: quantitative analysis of HER2 overexpression effects. , 2003, Cancer research.

[39]  M. Winget,et al.  Epidermal growth factor and transforming growth factor alpha bind differently to the epidermal growth factor receptor. , 1989, Biochemistry.

[40]  Erez M. Bublil,et al.  The EGF receptor family : spearheading a merger of signaling and therapeutics , 2007 .

[41]  Robert J Coffey,et al.  EGF receptor ligands. , 2003, Experimental cell research.

[42]  Y. Yarden,et al.  Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.

[43]  Cecilia Soderberg-Naucler,et al.  The Human Cytomegalovirus Chemokine Receptor US28 Mediates Vascular Smooth Muscle Cell Migration , 1999, Cell.

[44]  D. Lauffenburger,et al.  Affinity regulates spatial range of EGF receptor autocrine ligand binding. , 2002, Developmental biology.

[45]  G. Nemerow,et al.  Differential regulation of cell motility and invasion by FAK , 2003, The Journal of cell biology.

[46]  J. Welsh,et al.  Ligand-induced transformation by a noninternalizing epidermal growth factor receptor. , 1990, Science.

[47]  M. Sporn,et al.  Autocrine secretion and malignant transformation of cells. , 1980, The New England journal of medicine.

[48]  Sampsa Hautaniemi,et al.  Effects of HER2 overexpression on cell signaling networks governing proliferation and migration , 2006, Molecular systems biology.

[49]  Ken Jacobson,et al.  MAP kinases and cell migration , 2004, Journal of Cell Science.

[50]  G. Carpenter EGF Receptor Transactivation Mediated by the Proteolytic Production of EGF-like Agonists , 2000, Science's STKE.

[51]  M. Tsao,et al.  Autocrine growth loop of the epidermal growth factor receptor in normal and immortalized human bronchial epithelial cells. , 1996, Experimental cell research.

[52]  S. Bates,et al.  Expression of the transforming growth factor-alpha/epidermal growth factor receptor pathway in normal human breast epithelial cells. , 1990, Endocrinology.

[53]  J. Drazen,et al.  Bronchial epithelial compression regulates epidermal growth factor receptor family ligand expression in an autocrine manner. , 2005, American journal of respiratory cell and molecular biology.

[54]  R. Derynck,et al.  Ectodomain shedding of TGF‐α and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades , 1999, The EMBO journal.

[55]  H. Wiley,et al.  Differential signaling and regulation of apical vs. basolateral EGFR in polarized epithelial cells. , 1998, American journal of physiology. Cell physiology.

[56]  D. Lauffenburger,et al.  The Response of Human Epithelial Cells to TNF Involves an Inducible Autocrine Cascade , 2006, Cell.

[57]  J. Massagué,et al.  Multiple signals activate cleavage of the membrane transforming growth factor-alpha precursor. , 1991, The Journal of biological chemistry.

[58]  N. Normanno,et al.  Epidermal growth factor receptor (EGFR) signaling in cancer. , 2006, Gene.

[59]  A. Wells EGF receptor. , 1999, The international journal of biochemistry & cell biology.

[60]  J. Rosen Hormone receptor patterning plays a critical role in normal lobuloalveolar development and breast cancer progression. , 2003, Breast disease.

[61]  Christian Klämbt,et al.  Epidermal growth factor receptor signaling , 2001, Current Biology.

[62]  H. Wiley,et al.  Relationship between epidermal growth factor receptor occupancy and mitogenic response. Quantitative analysis using a steady state model system. , 1984, The Journal of biological chemistry.

[63]  G. Weskamp,et al.  Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands , 2004, The Journal of cell biology.

[64]  J. Willson,et al.  Growth stimulation by coexpression of transforming growth factor-alpha and epidermal growth factor-receptor in normal and adenomatous human colon epithelium. , 1990, The Journal of clinical investigation.

[65]  Jerry M Maniate,et al.  Targeting the EGFR pathway for cancer therapy. , 2006, Current medicinal chemistry.

[66]  A. Ullrich,et al.  EGFR signal transactivation in cancer cells. , 2003, Biochemical Society transactions.

[67]  H. Wiley,et al.  An integrated model of epidermal growth factor receptor trafficking and signal transduction. , 2003, Biophysical journal.

[68]  P. Dempsey,et al.  ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors. , 2006, American journal of physiology. Cell physiology.

[69]  Joshua LaBaer,et al.  Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[70]  J. Baselga,et al.  TACE is required for the activation of the EGFR by TGF-alpha in tumors. , 2003, The EMBO journal.

[71]  M. Bissell,et al.  Targeting TACE-dependent EGFR ligand shedding in breast cancer. , 2007, The Journal of clinical investigation.

[72]  Jia Yin,et al.  Lysophosphatidic acid promoting corneal epithelial wound healing by transactivation of epidermal growth factor receptor. , 2007, Investigative ophthalmology & visual science.

[73]  S. Bates,et al.  Expression of the transforming growth factor-alpha/epidermal growth factor receptor pathway in normal human breast epithelial cells. , 1990, Endocrinology.

[74]  J. Baselga,et al.  TACE is required for the activation of the EGFR by TGF‐α in tumors , 2003 .

[75]  E. Raines,et al.  Efficient expression of exogenous genes in primary vascular cells using IRES-based retroviral vectors. , 2002, BioTechniques.

[76]  D. Lauffenburger,et al.  Removal of the Membrane-anchoring Domain of Epidermal Growth Factor Leads to Intracrine Signaling and Disruption of Mammary Epithelial Cell Organization , 1998, The Journal of cell biology.

[77]  H. Wiley,et al.  Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking. , 2001, Molecular biology of the cell.

[78]  J. LaBaer,et al.  Cooperation of the ErbB 2 receptor and transforming growth factor in induction of migration and invasion in mammary epithelial cells , 2004 .